We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$282M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
| 3 |
ConocoPhillips
COP
|
+$203M |
| 4 |
Fortive
FTV
|
+$200M |
| 5 |
Merck
MRK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$665M |
| 2 |
ExxonMobil
XOM
|
+$332M |
| 3 |
Burlington
BURL
|
+$242M |
| 4 |
National Vision
EYE
|
+$186M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.03% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
FedEx
FDX
$74.1B
| $77.2M | 0.16% |
271,704
+3,500
| +1% | +$902K |
|
152
Fidelity National Information Services
FIS
$22.9B
| $76.7M | 0.16% |
545,279
-48,420
| -8% | -$6.61M |
|
153
Charter Communications
CHTR
$18.3B
| $76.2M | 0.16% |
123,537
-83,681
| -40% | -$52.3M |
|
154
Jabil
JBL
$35.6B
| $76.1M | 0.16% |
1,459,562
-487,024
| -25% | -$22.2M |
|
155
Norfolk Southern
NSC
$76.7B
| $74.9M | 0.15% |
279,006
-163,785
| -37% | -$41.5M |
|
156
Analog Devices
ADI
$185B
| $74.6M | 0.15% |
481,268
+95,611
| +25% | +$14.7M |
|
157
Colgate-Palmolive
CL
$73.8B
| $74.6M | 0.15% |
946,520
-8,000
| -0.8% | -$627K |
|
158
CenterPoint Energy
CNP
$27.4B
| $73.9M | 0.15% |
3,264,829
+588,400
| +22% | +$12.5M |
|
159
Curis
CRIS
$9.2M
| $73.6M | 0.15% |
16,250
+8,738
| +116% | +$36.5M |
|
160
Ametek
AME
$58.2B
| $72.2M | 0.15% |
565,434
-12,091
| -2% | -$1.46M |
|
161
Assurant
AIZ
$13.9B
| $72M | 0.15% |
507,540
+33,800
| +7% | +$4.55M |
|
162
United Therapeutics
UTHR
$22B
| $71.1M | 0.15% |
425,000
-400,000
| -48% | -$66.7M |
|
|
FLG
163
Flagstar Bank National Association
FLG
$5.95B
| $70.6M | 0.14% |
1,865,937
-114,613
| -6% | -$3.96M |
|
164
Howmet Aerospace
HWM
$115B
| $70.6M | 0.14% |
2,198,375
+1,502,001
| +216% | +$43.2M |
|
165
Becton Dickinson
BDX
$46.9B
| $69.9M | 0.14% |
294,600
-51,865
| -15% | -$12.7M |
|
166
Costco
COST
$420B
| $69.8M | 0.14% |
197,968
-99,200
| -33% | -$34.5M |
|
167
Intercontinental Exchange
ICE
$83.8B
| $69.5M | 0.14% |
622,690
-11,400
| -2% | -$1.29M |
|
168
Equinix
EQIX
$104B
| $67.4M | 0.14% |
99,168
-100
| -0.1% | -$68.6K |
|
169
Northrop Grumman
NOC
$78.4B
| $67.2M | 0.14% |
207,740
+48,893
| +31% | +$14.7M |
|
170
Duke Energy
DUK
$96.9B
| $67.2M | 0.14% |
696,160
-116,100
| -14% | -$10.6M |
|
171
Diodes
DIOD
$4.06B
| $67.2M | 0.14% |
841,265
-124,020
| -13% | -$9.81M |
|
|
FITB
172
Fifth Third Bancorp
FITB
$52.4B
| $67M | 0.14% |
1,788,362
+23,018
| +1% | +$781K |
|
173
International Flavors & Fragrances
IFF
$20.7B
| $66.3M | 0.14% |
474,881
+333,385
| +236% | +$43.1M |
|
174
RTX Corp
RTX
$294B
| $66.1M | 0.14% |
855,514
+277,486
| +48% | +$20.3M |
|
175
Ingersoll Rand
IR
$34.7B
| $66M | 0.13% |
1,341,570
+332,347
| +33% | +$15.4M |
|
Similar funds
Adage Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
- Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
- Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
- Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
- Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
- Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
- Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.
Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.